Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Debt / NOTE 2.625% 2/1
-
Market price (% of par)
-
90.17%
-
Total 13F principal
-
$106,265,846
-
Principal change
-
+$5,245,878
-
Total reported market value
-
$95,906,878
-
Number of holders
-
20
-
Value change
-
+$4,664,417
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 as of Q2 2020
As of 30 Jun 2020,
COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 was held by
20 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$106,265,846
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, SOROS FUND MANAGEMENT LLC, STEELHEAD PARTNERS LLC, LAZARD ASSET MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, MACQUARIE GROUP LTD, CALAMOS ADVISORS LLC, FMR LLC, Alberta Investment Management Corp, and GABELLI FUNDS LLC.
This page lists
20
institutional bondholders reporting positions
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.